Norinchukin Bank’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.35M Buy
5,059
+5
+0.1% +$1.35K 0.02% 388
2025
Q4
$1.27M Buy
5,054
+321
+7% +$85.3K 0.01% 399
2025
Q3
$1.36M Buy
4,733
+91
+2% +$24.4K 0.02% 369
2025
Q2
$1.22M Buy
4,642
+223
+5% +$54.3K 0.02% 383
2025
Q1
$1.03M Buy
4,419
+587
+15% +$142K 0.02% 383
2024
Q4
$879K Buy
3,832
+333
+10% +$76.4K 0.02% 387
2024
Q3
$782K Buy
3,499
+491
+16% +$108K 0.02% 394
2024
Q2
$612K Buy
3,008
+37
+1% +$7.53K 0.02% 390
2024
Q1
$649K Sell
2,971
-39
-1% -$8.59K 0.02% 383
2023
Q4
$684K Sell
3,010
-456
-13% -$95.8K 0.02% 361
2023
Q3
$697K Sell
3,466
-5,411
-61% -$1.14M 0.02% 354
2023
Q2
$1.58M Buy
8,877
+2,148
+32% +$417K 0.03% 342
2023
Q1
$1.33M Buy
6,729
+199
+3% +$40.9K 0.03% 320
2022
Q4
$1.32M Sell
6,530
-1,720
-21% -$336K 0.03% 309
2022
Q3
$1.45M Buy
8,250
+831
+11% +$170K 0.03% 311
2022
Q2
$1.49M Sell
7,419
-2,645
-26% -$564K 0.03% 294
2022
Q1
$2.28M Buy
10,064
+525
+6% +$123K 0.03% 295
2021
Q4
$2.58M Sell
9,539
-232
-2% -$57.4K 0.03% 268
2021
Q3
$2.36M Buy
9,771
+376
+4% +$94.8K 0.03% 264
2021
Q2
$2.23M Sell
9,395
-42
-0.4% -$9.57K 0.03% 263
2021
Q1
$2.07M Buy
9,437
+160
+2% +$32.1K 0.03% 271
2020
Q4
$1.62M Sell
9,277
-224
-2% -$38.7K 0.02% 287
2020
Q3
$1.54M Buy
9,501
+161
+2% +$25.5K 0.02% 275
2020
Q2
$1.33M Sell
9,340
-119
-1% -$16.5K 0.02% 295
2020
Q1
$1.03M Sell
9,459
-5,530
-37% -$797K 0.02% 309
2019
Q4
$2.18M Sell
14,989
-1,515
-9% -$219K 0.03% 315
2019
Q3
$2.38M Buy
16,504
+324
+2% +$47.3K 0.03% 299
2019
Q2
$2.4M Sell
16,180
-5,602
-26% -$782K 0.04% 292
2019
Q1
$2.86M Buy
21,782
+267
+1% +$32.9K 0.04% 304
2018
Q4
$2.34M Buy
21,515
+6,261
+41% +$839K 0.03% 310
2018
Q3
$2.28M Buy
15,254
+1,762
+13% +$268K 0.03% 288
2018
Q2
$2.08M Buy
13,492
+2,623
+24% +$396K 0.03% 272
2018
Q1
$1.51M Buy
10,869
+1,396
+15% +$205K 0.03% 304
2017
Q4
$1.3M Buy
9,473
+652
+7% +$86.2K 0.02% 331
2017
Q3
$1.14M Buy
8,821
+558
+7% +$74.4K 0.02% 338
2017
Q2
$1.09M Buy
8,263
+525
+7% +$64.3K 0.02% 343
2017
Q1
$954K Buy
7,738
+465
+6% +$55.1K 0.02% 357
2016
Q4
$802K Buy
7,273
+897
+14% +$99.6K 0.02% 371
2016
Q3
$753K Buy
6,376
+125
+2% +$14.7K 0.02% 371
2016
Q2
$700K Buy
6,251
+176
+3% +$18.9K 0.02% 356
2016
Q1
$611K Buy
6,075
+572
+10% +$54.8K 0.01% 386
2015
Q4
$585K Sell
5,503
-1,198
-18% -$124K 0.01% 374
2015
Q3
$624K Buy
6,701
+86
+1% +$8.9K 0.02% 390
2015
Q2
$689K Sell
6,615
-306
-4% -$31.9K 0.02% 383
2015
Q1
$750K Sell
6,921
-10,242
-60% -$1.05M 0.02% 378
2014
Q4
$1.59M Buy
17,163
+10,795
+170% +$954K 0.04% 240
2014
Q3
$557K Buy
6,368
+2,684
+73% +$243K 0.02% 318
2014
Q2
$324K Sell
3,684
-424
-10% -$36.7K 0.01% 390
2014
Q1
$347K Buy
4,108
+308
+8% +$24.6K 0.01% 395
2013
Q4
$298K Sell
3,800
-139
-4% -$11.9K 0.01% 397
2013
Q3
$335K Buy
3,939
+192
+5% +$16.2K 0.01% 364
2013
Q2
$322K Buy
+3,747
New +$311K 0.01% 339

Other funds holding LH

Norinchukin Bank's LH Position: Q1 2026 in Review

Norinchukin Bank increased its Labcorp (LH) stake by 0.1% in Q1 2026, buying an estimated $1.35K and bringing the position to 5,059 shares worth $1.35M. The position accounts for 0.02% of the portfolio, ranked #388.

Norinchukin Bank first reported a position in LH in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.86M in Q1 2019. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Norinchukin Bank held 5,059 shares of Labcorp worth $1.35M as of Q1 2026.
  • Norinchukin Bank bought 5 Labcorp shares in Q1 2026, an estimated $1.35K.
  • Labcorp made up 0.02% of Norinchukin Bank's portfolio in Q1 2026, its #388 holding.
  • Norinchukin Bank first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
  • Norinchukin Bank's Labcorp position peaked at $2.86M in Q1 2019.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Norinchukin Bank's 13F filing for Q1 2026, filed 15 May 2026.